2015, Number 3
Next >>
Rev Biomed 2015; 26 (3)
Chinkunguya en México: ¿A quién le toca limitar el daño derivado de esta enfermedad emergente?
Méndez DN
Language: Spanish
References: 3
Page: 117-118
PDF size: 174.83 Kb.
Text Extraction
No abstract.
REFERENCES
Javelle E, Ribera A, Degasne I, Marimoutou C, Simon F. Clinical spectrum of post-chikungunya rheumatic musculoskeletal disorders and use of disease-modifying antirheumatic drugs to treat the chronic inflammatory entities: 6-year experience from Reunion Island. BMC Infect Dis. 2014;14(Suppl 2):O20.
Sam C, Kümmerer BM, Chan Y-F, Roques P, Drosten C, AbuBakar S. Updates on Chikungunya Epidemiology, Clinical Disease, and Diagnostics. Vector Borne Zoonotic Dis. 2015;15(4):223-30.
Gallian P, De Lamballerie X, Salez N, Piorkowski G, Richard P, Paturel L, et al. Prospective detection of chikungunya virus in blood donors, Caribbean 2014. Blood. 2014;123(23):3679-81.
Full text